A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Status:
Recruiting
Trial end date:
2026-05-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of retatrutide in
participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets
of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep
apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24
visits.